Subacute Thyroiditis During Peginterferon Alfa Therapy for Chronic Hepatitis Delta

¹ Department of Internal Medicine, Division of Endocrinology and Metabolism, Dumlupınar University Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Turkey

² Department of Nuclear Medicine, Dumlupınar University Kütahya Evliya Çelebi Training and Research Hospital, Kütahya, Turkey

EJMO 2018, 2(3), 182–185; https://doi.org/10.14744/ejmo.2017.43434

Submitted: 5 October 2017 | Accepted: 20 December 2017 | Published: 7 May 2018

© 2018 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )

Download PDF

Cite

XML

Abstract

Subacute thyroiditis is a nonsuppurative inflammation of the thyroid gland. Although there are case reports on the formation of subacute thyroiditis in patients with hepatitis C virus (HCV) and hepatitis B virus (HBV) receiving interferon treatment, there are no reports regarding the development of subacute thyroiditis in patients with hepatitis D virus (HDV) receiving interferon treatment. Here, we present the case of a patient with subacute thyroiditis receiving peginterferon alfa-2a for chronic HDV and to our knowledge this is the first report in the literature.

Keywords

Hepatit D virus (HDV)

interferon

subacute thyroiditis

Conflict of interest

None declared.

References

1. Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985;1:1166. [CrossRef]
2. Menconi F, Hasham A, Tomer Y. Environmental triggers of thyroiditis: hepatitis C and interferon-α. J Endocrinol Invest 2011;34:78–84. [CrossRef]
3. Paraná R, Cruz M, Lyra L, Cruz T. Subacute thyroiditis during treatment with combination therapy (interferon plus ribavirin) for hepatitis C virus. J Viral Hepat 2000;7:393–5. [CrossRef]
4. Abbas Z, Khan MA, Salih M, Jafri W. Interferon alpha for chronic hepatitis D. Cochrane Database Syst Rev 2011:CD006002.
5. Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, et al. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 1997;26:206–10. [CrossRef]
6. Tomer Y, Menconi F. Hepatitis C and interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab 2009;23:703–12.
7. Tomer Y, Blackard JT, Akeno N. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am 2007;36:1051-66. [CrossRef]
8. Suvak B, Dulger AC, Aykaç MC, Gonullu H, Gonullu E. Delta hepatitis-related thyroid disease: a unique phenomenon. Prz Gastroenterol 2015;10:169–72. [CrossRef]
9. Rizzetto M, Smedile A. Pegylated interferon therapy of chronic hepatitis D: in need of revision. Hepatology 2015;61:1109–11.
10. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011;378:73–85. [CrossRef]

Previous article in this issue

Next article in this issue

Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing